| # | Drug | Count |
|---|---|---|
| 0 | TRASTUZUMAB | 234 |
| 1 | PERTUZUMAB | 122 |
| 2 | PACLITAXEL | 72 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 70 |
| 4 | DOCETAXEL | 62 |
| 5 | DOCETAXEL ANHYDROUS | 62 |
| 6 | CAPECITABINE | 54 |
| 7 | CYCLOPHOSPHAMIDE | 54 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 54 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMLUNESTRANT | 1 | 0.0109 |
| 1 | NERATINIB | 11 | 0.0047 |
| 2 | PERTUZUMAB | 122 | 0.0044 |
| 3 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 4 | TRASTUZUMAB | 234 | 0.0034 |
| 5 | ADO-TRASTUZUMAB EMTANSINE | 28 | 0.0033 |
| 6 | FLURANDRENOLIDE | 1 | 0.0030 |
| 7 | PRUCALOPRIDE SUCCINATE | 1 | 0.0029 |
| 8 | TRASTUZUMAB-ANNS | 4 | 0.0026 |
| 9 | FINGOLIMOD HYDROCHLORIDE | 10 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 245 |
| 1 | Microtubule Inhibitor [EPC] | 107 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 63 |
| 3 | Alkylating Drug [EPC] | 54 |
| 4 | Kinase Inhibitor [EPC] | 41 |
| 5 | Aromatase Inhibitor [EPC] | 39 |
| 6 | Platinum-based Drug [EPC] | 21 |
| 7 | Corticosteroid [EPC] | 19 |
| 8 | Estrogen Receptor Antagonist [EPC] | 16 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 245 | 0.0033 |
| 1 | Monobactam Antibacterial [EPC] | 6 | 0.0022 |
| 2 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Microtubule Inhibitor [EPC] | 107 | 0.0006 |
| 5 | Antifibrinolytic Agent [EPC] | 6 | 0.0006 |
| 6 | Vitamin K [EPC] | 5 | 0.0006 |
| 7 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 8 | 0.0006 |
| 8 | Estrogen Receptor Antagonist [EPC] | 16 | 0.0004 |
| 9 | Aromatase Inhibitor [EPC] | 39 | 0.0003 |